This paper makes the case for exosome therapy as a safer, more refined alternative to whole-cell mesenchymal stem cell therapy. By using just the secreted exosomes, clinicians can deliver the regenerative benefits of stem cells without some of the risks associated with administering live cells.

For patients evaluating regenerative options, this article provides useful context for why exosome therapy is increasingly preferred in many clinical settings.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.